Veracyte’s approach to breast cancer treatment decision-making
EXCEPTIONAL TESTING FOR BREAST CANCER
Better prognostic information with the Prosigna® Breast Cancer Assay
Veracyte’s Prosigna Breast Cancer Assay is a genomic test designed to support more precise and timely treatment decisions for women with early-stage, HR+/HER2- breast cancer. The test analyzes the activity of 50 genes known as the PAM50 gene signature, combined with key clinical information, to provide a prognostic score. This score indicates the potential that an individual patient’s cancer will recur within the next 10 years. This information can help clinicians and their patients make more precise and timely treatment decisions. The Prosigna test also provides breast cancer molecular subtype information for the clinician’s additional reference.
Learn about the Prosigna assay for breast cancer
Cancer. World Health Organization. Published February 3, 2022. Accessed July 19, 2023. https://www.who.int/news-room/fact-sheets/detail/cancer
Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15-23. doi:10.1016/j.breast.2022.08.010
Breast Cancer. World Health Organization. Published July 12, 2023. Accessed July 27, 2023. https://www.who.int/news-room/fact-sheets/detail/breast-cancer
Breast Cancer Treatment (PDQ®)–Health Professional Version. National Cancer Institute. Accessed July 27, 2023. https://www.cancer.gov/types/breast/hp/breast-treatment-pdq
The Prosigna Breast Cancer Assay is FDA-cleared and CE-marked. For availability in individual EU countries and other territories outside of the US, please check with your local representative or distributor.
This website contains information on products that are targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for you accessing such information that may not comply with any legal process, regulation, registration or usage in the country of your origin.